Quest Diagnostics’ XSense test, which is used to screen for fragile X syndrome, has been approved by New York State’s department of health. The firm launched it in the rest of the US in February; however, New York has an independent regulatory review process for lab-developed ...
Clinica
Quest’s fragile X test approved in New York
29 July 2010
Madeleine Armstrong
Not a subscriber ? Request a FREE Trial
Subscribe to Clinica
RELATED CONTENT
NEWS
Clinica News
Other Informa News
Features & Analysis
Other Informa Analysis
EVENTS
19 March 2012
Montreux Convention and Music Centre, Switzerland
